Literature DB >> 1921678

Behavioral correlates of sympathoadrenal reactivity: the toughness model.

R A Dienstbier1.   

Abstract

Research with humans is reviewed showing that increased levels of urinary epinephrine (EPI) and norepinephrine (NE) from samples taken following mental challenge/stress situations are associated with better performance in those situations and with emotional stability. Another research tradition with humans and animals shows that various training protocols lead to increased peripheral and central catecholamine capacities. Those training protocols include continuous exposure to cold, periodic exposure to some intermittent stressors such as foot or tail shock (with intervening rest periods), or programs of aerobic exercise. While increasing catecholamine capacities, those procedures also result in lower base rates of the catecholamines and with the delay of pituitary-adrenal-cortical responses in challenge/stress contexts. That physiological pattern of "toughness" leads to improved performance in challenge/stress situations, increased tolerance of stressors (i.e., reduced behavioral suppression or depression), emotional stability, and immune system enhancement. The special conditions are discussed that are required for demonstrating increased catecholamine capacities rather than the attenuation of arousal associated with increased muscular and neuroendocrine efficiency. Finally, the role played by toughness in reducing anxiety while increasing energy in challenge/stress situations is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1921678

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  10 in total

1.  Lorry drivers' work stress evaluated by catecholamines excreted in urine.

Authors:  A J van der Beek; T F Meijman; M H Frings-Dresen; J I Kuiper; S Kuiper
Journal:  Occup Environ Med       Date:  1995-07       Impact factor: 4.402

Review 2.  Walking to health.

Authors:  J N Morris; A E Hardman
Journal:  Sports Med       Date:  1997-05       Impact factor: 11.136

3.  New resilience instrument for patients with cancer.

Authors:  Zeng Jie Ye; Mu Zi Liang; Peng Fei Li; Zhe Sun; Peng Chen; Guang Yun Hu; Yuan Liang Yu; Shu Ni Wang; Hong Zhong Qiu
Journal:  Qual Life Res       Date:  2017-11-08       Impact factor: 4.147

4.  Physical activity moderates effects of stressor-induced rumination on cortisol reactivity.

Authors:  Eli Puterman; Aoife O'Donovan; Nancy E Adler; A Janet Tomiyama; Margaret Kemeny; Owen M Wolkowitz; Elissa Epel
Journal:  Psychosom Med       Date:  2011-08-26       Impact factor: 4.312

Review 5.  Neuroendocrine-immune interactions and responses to exercise.

Authors:  Maren S Fragala; William J Kraemer; Craig R Denegar; Carl M Maresh; Andrea M Mastro; Jeff S Volek
Journal:  Sports Med       Date:  2011-08-01       Impact factor: 11.136

Review 6.  Exercise and the treatment of clinical depression in adults: recent findings and future directions.

Authors:  Alisha L Brosse; Erin S Sheets; Heather S Lett; James A Blumenthal
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

7.  Emotion-induced amnesia in rats: working memory-specific impairment, corticosterone-memory correlation, and fear versus arousal effects on memory.

Authors:  James C Woodson; Deric Macintosh; Monika Fleshner; David M Diamond
Journal:  Learn Mem       Date:  2003 Sep-Oct       Impact factor: 2.460

8.  The antidepressive effects of exercise: a meta-analysis of randomized trials.

Authors:  Chad D Rethorst; Bradley M Wipfli; Daniel M Landers
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

Review 9.  The effects of stress on physical activity and exercise.

Authors:  Matthew A Stults-Kolehmainen; Rajita Sinha
Journal:  Sports Med       Date:  2014-01       Impact factor: 11.136

Review 10.  Biological mechanisms underlying the role of physical fitness in health and resilience.

Authors:  Marni N Silverman; Patricia A Deuster
Journal:  Interface Focus       Date:  2014-10-06       Impact factor: 3.906

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.